Public and private, Hospital in Midland, Australia

Australian government on Monday gave recognition to Bharat Biotech's Covaxin COVID-19 vaccine for the purpose of establishing a traveller's vaccination status in the country."Today, the Therapeutic Goods Administration determined that Covaxin (manufactured by BharatBiotech) vaccine would be 'recognised' for the purpose of establishing a traveller's vaccination status," Australia's High Commissioner to India Barry O'Farrell informed in a tweet."Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca India, means many citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia," the High Commissioner added in the tweet.COVID-19 vaccines are approved for use in Australia by the Therapeutic Goods Administration (TGA) after an assessment and approval process."In recent weeks, the TGA has obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19," a statement from Australia's Department of Health informed.Recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca, India), means many citizens of India, as well as other countries where these vaccines have been widely deployed, will now be considered fully vaccinated on entry to Australia, the statement said."This will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia," the statement added.From 1 November 2021, vaccinated Australians and permanent residents aged 12 and over may depart Australia without the need to seek a travel exemption, the Australian Health Department said.The UN health body -- World Health Organisation -- has sought additional clarifications from Bharat Biotech, which manufactures Covaxin and a decision on emergency use authorisation is expected early next month.WHO giving approval for Emergency Use Authorisation for India's indigenous COVID-19 vaccine 'Covaxin' would facilitate the process of assisting other countries, Foreign Secretary Harsh Vardhan Shringla said on Saturday addressing a media briefing on the first day of G20 summit in Rome.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Public And PrivateFOLLOW

Public and private, Latest News

Knowing net run-rate may be a decisive factor in Australia's qualification for the semi-finals of the ICC men's T20 World Cup 2021, spinner Adam Zampa revealed they had to be aggressive from the start. ...

Dubai, Nov 4 Adam Zampa shined with a five-wicket haul as Australia decimated a hapless Bangladesh by eight ... ...

Dubai, Nov 4 Australia made short work of a small chase to beat Bangladesh by eight wickets in ... ...

Australian fast bowler James Pattinson said that he is thankful to have the opportunity to represent his country in international cricket but he cannot push his body any further to play Test cricket again. ...

Canberra, Nov 3 Australian Prime Minister Scott Morrison on Wednesday greeted Ind living there on the occasion of ... ...

Dubai, Nov 3 Jos Buttler's hammering would have rattled one of the title favourites Australia in the ICC ... ...

Pooja Advani's day begins with her checking up on her guests. Then comes the bitter-sweet bit - check-ins and checkouts. Waving goodbye to those who've come to become friends, and saying hello to new and enthusiastic wet noses and wagging tails. ...

Australian government on Monday gave recognition to Bharat Biotech's Covaxin COVID-19 vaccine for the purpose of establishing a traveller's vaccination status in the country. ...